Vitamin A for Health & Longevity - Quick Reference Sheet
evipedia.ai ← Back

Vitamin A for Health & Longevity

Created on 06/30/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

An essential nutrient that is clearly valuable only in genuine deficiency. In well-nourished adults, added vitamin A does not lengthen life or prevent heart disease, and routine excess can build up to harm the liver, raise hip fracture risk, cause birth defects in pregnancy, and increase lung cancer in smokers. Best matched to actual need, with food sources safest. (Full Review)

Protocol

Dose
700–900 mcg RAE/day
RDA maintenance for confirmed deficiency; higher short-course doses under supervision.
When
With a fat-containing meal
Maximizes absorption of this fat-soluble nutrient; time of day is not critical.
Form
Food-first, carotenoids preferred
Daily maintenance taken as a single dose with food; reserve low-dose cod liver oil for non-organ-meat eaters.
Time to effect
Night blindness
Days to weeks
Improves after repletion in deficiency; no meaningful effect to expect in replete adults.

Benefits

Contraindications
  • Oral retinoid medications (isotretinoin, acitretin, tretinoin, bexarotene)
  • Pregnancy or those who may become pregnant
  • Current smokers and asbestos-exposed individuals
  • Liver disease (Child-Pugh Class B–C cirrhosis)
  • Hypervitaminosis A
  • Chronic kidney disease with impaired retinol clearance
    •
Key Interactions
  • Anticoagulants (warfarin and other vitamin K antagonists)
  • Hepatotoxic agents and high alcohol intake
  • Orlistat and bile-acid sequestrants (cholestyramine, colestipol)
  • Tetracycline-class antibiotics (doxycycline, minocycline)
  • Other fat-soluble vitamins (D, E, K)
  • Beta-carotene supplements
    •

Risk & Side Effects

  • High: Chronic hypervitaminosis A; increased lung cancer and mortality in smokers; teratogenicity
    •
  • Medium: Increased hip fracture risk; all-cause mortality signal with high-dose supplements
    •
  • Low: Carotenodermia
    •
  • Speculative: Acute hypervitaminosis A from single massive doses
    •

Monitoring

Marker Target Why
Serum retinol 0.52–2.05 µmol/L (mid-range preferred) Confirms adequacy vs. deficiency or excess
Liver enzymes (ALT, AST) ALT < 25 U/L, AST < 25 U/L Detect early hepatotoxicity from accumulation
Serum beta-carotene Reflects intake; no deficiency threshold Gauges carotenoid intake and conversion
25-hydroxyvitamin D 40–60 ng/mL Co-status influences vitamin A bone safety

Cadence: Recheck serum retinol and liver enzymes at 3 months after initiation, then every 6–12 months during continued use; earlier if toxicity symptoms appear.

Qualitative Assessment

  • Night-vision quality (improvement signals successful repletion of deficiency)
  • Skin and mucous-membrane condition (dryness or excessive dryness/peeling as a toxicity sign)
  • Headache, joint or bone pain, and visual disturbance (early warning signs of hypervitaminosis A)
  • Energy and general well-being (persistent malaise on higher doses warrants reassessment)
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.